Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial

Bretzel, RG, Nuber, U, Landgraf, W, Owens, DR, Bradley, Clare and Linn, T

(2008)

Bretzel, RG, Nuber, U, Landgraf, W, Owens, DR, Bradley, Clare and Linn, T (2008) Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial. The Lancet, 371 (9618).

Our Full Text Deposits

Full text access: Open

Full text file - 418.54 KB

Links to Copies of this Item Held Elsewhere

Link to publisher copy

Link to publisher copy

Link to publisher copy

Abstract

Information about this Version

This is a Approved version
This version's date is: 29/3/2008
This item is not peer reviewed

Link to this Version

https://repository.royalholloway.ac.uk/items/c5b86fca-ede9-05d6-95c6-148df72e4e5a/7/

Item TypeJournal Article
TitleOnce-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial
AuthorsBretzel, RG
Nuber, U
Landgraf, W
Owens, DR
Bradley, Clare
Linn, T
Departments

Identifiers
doihttp://dx.doi.org/10.1016/S0140-6736(08)60485-7

Deposited by Research Information System (atira) on 19-Jun-2013 in Royal Holloway Research Online.Last modified on 19-Jun-2013

Details